CODE BST DESCRIPTION PVP 2019

Transcription

1 Transfusion Safety Laboratory Transfusional Security 0165 Citomegalovirus, IgG. Screening 2, Citomegalovirus, IgM. Screening 2, Citomegalovirus, DNA 61, Epstein-Barr, IgG anti-ebna. Screening 6, Epstein-Barr, IgG anti-vca. Screening 6, Epstein-Barr, IgM anti-vca. Screening 6, Hepatitis B, IgM anti-core. Screening 6, Hepatitis B, anti surface antigen Ab 6, Hepatitis B, core IgG+IgM. Screening 2, Hepatitis B. Surface antigen. Confirm. 21, Hepatitis B. Surface antigen. Screening 3, HCV RNA, VIH1/2 RNA & HBV DNA Screening 16, Hepatitis C, IgG. Immunoblot 52, Hepatitis C, IgG. Screening 3, Hepatitis E, IgG. Screening 30, Hepatitis E, IgM. Screening 30, Hepatitis E, RNA (TMA). Screening 23, HTLV I/II, IgG. Immunoblot 60, HTLV I/II, IgG. Screening 6, HTLV-I, DNA proviral 30, Plasmodium sp, IgG,IgM,IgA Screening 8, Toxoplasma gondii, IgG. Screening 1, Toxoplasma gondii, IgM. Screening 2, Treponema pallidum, IgG. Immunoblot 30, Treponema pallidum, IgG+IgM. Screning 2, Trypanosoma cruzi, IgG. Screening 7, Trypanosoma cruzi, DNA 21, HIV I/II IgG Immunoblot 70, VIH-1/VIH-2. IgG. Screening 3, VIH-1/VIH-2, IgG/antigen P24. Screening 3,24 Immunohematology Laboratory Erytrocytes 0009 ABO/Rho(D) Group 5, Irregular Antibodies Scrutiny 14, Irregular Antibodies Id 60, Direct antiglobulin test (CD) 10, Eluted erythrocyte Ab 56, Auto/Allo Absorption erythrocyte Ab 91, Discrepancy study group ABO 75, Antibody anti G study 91, Thermal amplitude of an antibody 60, Class lg identification 49, Ab neutralization 49, Donath-Landsteiner test 96, Rh D 5, Rh C 5, Rh c 5, Rh E 5, Rh e 5, Bombay 18, Kell 14, Cellano 14, Kpa 14,73 Page 1

2 0513 Kpb 14, Jsa 14, Jsb 14, Fya 14, Fyb 14, Ge2 (Gerbich 2) 18, VS (RH20) 18, Hy (Holley) 18, Joa (Joseph) 18, Yka (York) 18, Jka 14, Jkb 14, Lua 14, Lub 14, Lea 14, Leb 14, Vel 14, Jra 14, P1 14, M 14, N 14, S 14, s 14, Lan (Langereis) 18, Cw 14, PP1Pk 14, Xga 14, P1k 18, P2k 18, Yta (Cartwright a) 14, Ytb (Cartwright b) 14, Wra (Wright) 14, Coa (Colton a) 14, Cob (Colton b) 14, Do a (Dombrock a) 14, Do b (Dombrock b) 14, Di a (Diego a) 14, Di b (Diego b) 14, Ch a (Chido a) 14, I 14, H 14, Kna (Knops a) 14, Rh 46 14, Genotype Rh (D) 36, Genotype ABO 75, Genotype Kidd 58, Genotype Kell 58, Genotype Kpa/b 58, Genotype Jsa/b 58, Genotype Lu 58, Genotype Wright 58, Genotype Cartwright 58, Genotype Knops 58, Genotype MNSs 58, Genotype CcEe 51, Genotype Duffy 58, Genotype Colton 58,95 Page 2

3 4967 Genotype Dombrock 58, Genotype Diego 58, Genotype Vel 58, Genotype York 58, Rh/(D) zygosity 158, Isohemagglutinins anti-a 22, Cryohemaglutinines 11, Isohemagglutinins anti-b 22, Irregular antibodies titration 22, Fixation-Elution Ab study 79, Rh(D) expression with monoclonal Ab 97, Special molecular studies 513, Molecular RhD typing 182, Other genotypes 37, Hemolytic anemia induced by drugs 49, Antibody hemolytic activity 273, Antiglobulin Quality Control 41, High complexity specimen study 286, Fetal erythocytes in mother blood 124, Erythrocyte cross matching 13, Polyagglutination 183, Ab against low ang high Ag frequency 126, Compat.test patient treated monocl.antib 127, Neutralization with recombinant proteins 103, Ham test 30, HPN 124, Complete genotyping 317,25 Platelets 0600 HPA-1a (PIA1, Zwa) Platelet Ag 10, HPA-1b (PIA2, Zwb) Platelet Ag 10, HPA-2a (Kob) Platelet Ag 10, HPA-2b (Koa, Siba) Platelet Ag 10, HPA-3a (Baka) Platelet Ag 10, HPA-3b (Bakb) Platelet Ag 10, HPA-4a (Yukb, Pena) Platelet Ag 10, HPA-4b (Yuka, Penb) Platelet Ag 10, HPA-5a (Brb) Platelet Ag 10, HPA-5b (Bra) Platelet Ag 10, HPA-15b (Gova) Platelet Ag 10, HPA-15a (Govb) Platelet Ag 10, Platelet Ab identification 124, Platelet cross match (MAIPA) 75, Platelet antibodies (MAIPA HPA-15) 75, Autoimmune thrombocytopenia study 124, Membrane glycoproteins 121, Platelet cryptoantigen Ab 124, Platelet antibodies (MAIPA) 75, Platelet refractoriness study 188, Platelet genotype 51, Platelet antibodies (indirect test) 43, Platelet cross match 37, IgA deficiency (agglutination) 20, IgA antibodies 20, IgA deficiency (ELISA) 101, Drug-induced thrombocytopenia study 179, Platelet antibodies (direct test) 34, Platelet antibodies (solid phase) 62,52 Page 3

4 4969 Platelet antibodies titration 227, Anti-HLA I antibodies 60, Anti-HLA II antibodies 60,75 Granulocytes 4983 Granulocyte antibodies (Luminex) 152, Granulocyte antibodies (direct test) 48, Granulocyte antibodies (indirect test) 116, Autoimmune neutropenia study 165, Granulocyte phenotype (HNA-1,2,3) 98, Granulocyte genotype 126, Granuloagglutination 70, MAIGA (Granulocytes) 45, Drug-induced neutropenia study 179,30 Transplant follow-up. Chimerism 4009 STR markers analysis 201, Pre-HPT microsatellite study 201, Serologic chimera study 39, Chimerism post HPT, blood marrow 198, Chimerism post HPT, blood 201, Chimerism subpopulations, blood marrow 253, Chimerism subpopulations, blood 253,13 Fetal studies in maternal plasma 4951 Fetal sex in maternal plasma 141, Fetal HPA 1a genotype in maternal plasma 253, Fetal HPA genotype in amniotic fluid 99, Fetal Kell genotype in maternal plasma 253, Fetal Rh(c) genotype in maternal plasma 99, Fetal Rh(D) genotype in amniotic fluid 99, Fetal Rh(D) genotype in maternal plasma 99, Fetal Rh(E) genotype in maternal plasma 253,13 Immunogenetics Laboratory HLA typing LRD2025 High resolution HLA confirmation 156,24 LRD2024 Low resolution HLA confirmation 92,40 LRD2001 HLA B27 12,46 LRD2102 Genetic study CCR5 delta32 25,31 LRD2813 Immunoglobulin reordering 53,94 LRD2814 TCR reordering 53,94 LRD2060 Immunodeficiency, exome study 1.007,44 LRD2055 HLA genotype associated to Celiaquia 49,35 LRD2051 HLA genotype associated to Behçet 49,35 LRD2052 HLA genotype associated to Narcolepsy 49,35 LRD2019 High resolution HLA-A genotype 143,73 LRD2003 Low resolution HLA-A genotype 92,40 LRD2020 High resolution HLA-B genotype 143,73 LRD2004 Low resolution HLA-B genotype 97,53 LRD2021 High resolution HLA-C genotype 143,73 LRD2005 Low resolution HLA-C genotype 77,00 LRD2012 High resolution HLA-DPD1 genotype 161,34 LRD2011 High resolution HLA-DQB1 genotype 143,73 LRD2010 Low resolution HLA-DQB1 genotype 92,40 LRD2009 High resolution HLA-DRB1 genotype 143,73 LRD2008 Low resolution HLA-DRB1 genotype 92,40 LRD2058 'High HLA-DRB3/B4/B5 genotype 143,73 Page 4

5 LRD2057 KIR genotype 92,40 LRD2056 HLA-B* ,35 LRD2017 HLA I antibody identification 133,47 LRD2059 HLA II antibody identification 133,47 LRD2016 HLA I-II antibody screening 35,90 LRD2099 Urgency plus 65,66 LRD2104 NGS complete HLA genotype 450,00 Congenital Coagulopathies Laboratory Congenital coagulopathies LRD2222 B Hemophilia Molecular diagnostic 276,43 LRD2223 Congenital coagulopathies familiar study 157,96 LRD2224 F8 inversion study (intron 22,1) 157,96 LRD2235 Congenital coagulopathies prenatal study 684,50 LRD2810 DNA extraction 15,40 LRD2829 Clinical exome 1.007,44 Cellular Laboratory Cellular Laboratory CEL001 Clonogenic culture 42,25 CEL002 Duplicate clonogenic culture 84,50 CEL003 Cell count 6,44 CEL004 Erythroblasts 6,44 CEL005 Erythroblasts (manual) 34,35 CEL006 Quantification / viability CD3 and CD45 35,41 CEL007 Quantification/viabil. CD3 & CD45 ISHAGE 37,91 CEL008 Viability CD3 and CD45 7AAD + AnnexinV 37,91 CEL009 Viability CD34 and CD45 7AAD + AnnexinV 37,91 CEL010 Lymphocyte subpopulations 91,35 CEL011 CD45 RO/Raand subpopulation analysis 159,00 CEL012 CD34 selection labelling control 25,27 CEL013 Trypan Blue Viability 6,05 CEL014 Mesenchymal cells phenotype 91,35 CEL015 Quantif. / viab. of mesenchymal cells 35,41 CEL016 Quantif. of specific T cell lymphocytes 159,69 CEL017 CD133 / CD34 Expression 37,91 CEL018 Phenotypic characterization of platelets 139,52 CEL019 Viable CD271 count 37,91 CEL020 Osteogenic different. mesenchymal cells 1.171,86 CEL021 Immunomodulation mesenchymal cells 1.150,40 CEL022 TCRα / β + quantification 91,35 CEL023 Viability mesench. cells (ATP-lumines.) 97,80 CEL024 Biological activ.serum as culture suppl. 538,08 CEL025 Mycoplasma detection (ATP-luminescence) 69,89 CEL026 Interferon gamma secretion assay 1.012,50 CEL027 ELISPOT T-specific virus lymphocytes 123,63 CEL028 Endotoxins (kinetic colorimetry) 93,71 CEL029 Isolation of nucleated cells 33,56 CEL030 Freezing of nucleated cells 10,00 CEL031 Endotoxin validation (price per sample) 103,06 Page 5